Cardiotoxicity, heart electrophysiology dysfunction or muscle damage, is one of the most common reasons why drugs are withdrawn from the market. Now, researchers have created a computer model capable ...

A chemotherapy drug used to fight bone-marrow cancer also has the potential to treat and prevent potentially deadly heart failure, a powerful new drug-screening tool developed at UVA Health suggests.

Starting this fall, the FDA plans to trial an innovative new computational medicine approach to heart surgery with 160 patients in the US. The procedure, called Optimal Target Identification via ...

Research from a collaborative team of biomedical engineers, physicians and scientists could enable significant advances for the 40,000 pediatric congenital heart disease patients (CHD) born each year.